The value of monitoring minimal residual disease in the patients with donor lymphocyte infusion as intervention of relapsed/refractory acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation
1. Department of Hematology, Jiangsu Institute of Hematology, The First Affiliated Hospital of Suzhou University, Suzhou 215006, People's Republic of China;2. Department of Hematology, the CHU of Nantes, Nantes 44093, France